Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,261 articlesHims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
A major investor liquidated a sizable stake as the decking stock down 35% over the past year. This article breaks dow...
As oil prices surge toward triple digits, Trump volleyed calls for immediate rate cuts from Powell. The Fed appears p...
A missing, nationwide accounting of subsidies per affordable unit clouds the price tag of affordable housing. This re...
Ethereum is reclaiming the $2,000 zone and shaping a clearer path higher as traders assess the next breakout. The nex...
During a housing correction, buyers and homeowners rethink loan choices. This guide breaks down what we’re buying dur...
Two under-the-radar names—Albertsons and H&R Block—posted results that underscore a defensive stance for investors. B...
A fast-growing mezcal market in Oaxaca is boosting U.S. demand while driving environmental costs. New data show fores...
As Palantir tightens its client base, investors are weighing shares of its partners as cheaper ways to ride Palantir'...
Crypto advocates urge the Senate Banking Committee to protect DeFi protections and stablecoin rewards as hearings app...
Team (TISI) kicks off 2025 with a solid Q1 showing that blends growing customer demand with margin challenges. This a...